High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy-Reference-Cited by-同舟云学术

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Published:2009-11-10 Issue:1 Volume:127 Page:138-147
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

He Li-Ru,Liu Meng-Zhong,Li Bin-Kui,Jia Wei-Hua,Zhang Ying,Liao Yi-Ji,Chen Yang-Chao,Zhang Lan-Jun,Guan Xin-Yuan,Zeng Yi-Xin,Kung Hsiang-Fu,Xie Dan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Global cancer statistics, 2002. CA Cancer;Parkin;J Clin,2005

2. Treatment of localized esophageal cancer;Brenner;Semin Oncol,2004

3. Esophageal cancer: preoperative or definitive chemoradiation;Urba;Ann Oncol,2004

4. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus;Stahl;J Clin Oncol,2005

5. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus;Rohatgi;Cancer,2005

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non Coding RNA Participates in Epigenetic Modification of Esophageal Cancer;Advances in Clinical Medicine;2024

2. EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway;Medical Oncology;2023-08-27

3. Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma;Clinical and Translational Medicine;2022-05

4. DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway;Cancer Cell International;2022-03-05

5. Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism;Cancer Genomics - Proteomics;2022